1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow IBI302: new trials by email Literature Review of IBI302 trials Research Report on IBI302
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of IBI302 in Patients With nAMD Low dose IBI302, High dose IBI302, Aflibercept - Neovascular Age-related Macular Degeneration | Phase 2 | Completed | Innovent Biologics (Suzhou) Co. Ltd. | 231 | 2021-04-28 | 2024-11-18 |
Innovent Biologics (Suzhou) Co. Ltd. (1)
China (1)